Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 58, Issue 1, Pages -
Publisher
American Society for Microbiology
Online
2019-10-25
DOI
10.1128/jcm.01120-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay
- (2019) I. Benoy et al. JOURNAL OF CLINICAL VIROLOGY
- Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
- (2018) Lan Xu et al. JOURNAL OF CLINICAL VIROLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical and analytical evaluation of the Anyplex II HPV HR Detection assay within the VALGENT-3 framework
- (2018) Anja Oštrbenk et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
- (2017) N. J. Polman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- A cohort study of cervical screening using partial HPV typing and cytology triage
- (2016) Mark Schiffman et al. INTERNATIONAL JOURNAL OF CANCER
- Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting
- (2016) Mario Poljak et al. JOURNAL OF CLINICAL VIROLOGY
- VALGENT: A protocol for clinical validation of human papillomavirus assays
- (2016) Marc Arbyn et al. JOURNAL OF CLINICAL VIROLOGY
- Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
- (2016) Mario Poljak et al. JOURNAL OF CLINICAL VIROLOGY
- Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations
- (2016) Julia C. Gage et al. OBSTETRICS AND GYNECOLOGY
- Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
- (2016) Maaike G Dijkstra et al. BMJ-British Medical Journal
- Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
- (2016) Maaike G Dijkstra et al. BMJ-British Medical Journal
- Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening
- (2015) Jennifer L. Reid et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
- (2015) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results
- (2015) Mark Schiffman et al. GYNECOLOGIC ONCOLOGY
- Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
- (2015) Warner K. Huh et al. GYNECOLOGIC ONCOLOGY
- Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
- (2015) Thomas C. Wright et al. GYNECOLOGIC ONCOLOGY
- Long-term HPV type-specific risks for ASCUS and LSIL: A 14-year follow-up of a randomized primary HPV screening trial
- (2014) K. Miriam Elfström et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
- (2014) Louise T. Thomsen et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial
- (2014) Vitaly Smelov et al. INTERNATIONAL JOURNAL OF CANCER
- A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
- (2014) M. Schiffman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
- (2014) K. M. Elfstrom et al. BMJ-British Medical Journal
- Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: A cross-sectional observational study in Wales and Scotland (UK)
- (2013) Ned Powell et al. JOURNAL OF CLINICAL VIROLOGY
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
- (2012) Wiebren A. Tjalma et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up
- (2012) Philip E. Castle et al. JOURNAL OF CLINICAL ONCOLOGY
- Don’t Forget HPV-45 in Cervical Cancer ScreeningThe Authors’ Reply
- (2011) Wiebren A.A. Tjalma et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
- (2011) Henry C. Kitchener et al. EUROPEAN JOURNAL OF CANCER
- Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening
- (2011) M. Poljak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Long-Term Persistence of Prevalently Detected Human Papillomavirus Infections in the Absence of Detectable Cervical Precancer and Cancer
- (2011) Philip E. Castle et al. JOURNAL OF INFECTIOUS DISEASES
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test
- (2009) Ning Tang et al. JOURNAL OF CLINICAL VIROLOGY
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- (2008) Chris J.L.M. Meijer et al. INTERNATIONAL JOURNAL OF CANCER
- Cervical cancer screening following prophylactic human papillomavirus vaccination
- (2008) Eduardo L. Franco et al. VACCINE
- Monitoring HPV vaccination
- (2008) Margaret Stanley et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search